Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Lillian D. Sun"'
Autor:
Lillian D, Sun, Samantha, Polly, Jennifer S, Ko, Kristin, Ricci, Eric D, Hsi, Kevin D, Cooper, Anthony P, Fernandez
Publikováno v:
Photodermatology, Photoimmunology & Photomedicine. 38:600-603
Autor:
Lillian D. Sun, Joshua Arbesman
Publikováno v:
Clinics in Plastic Surgery. 48:551-560
Melanoma is the most lethal type of skin cancer, originating from the uncontrolled proliferation of melanocytes. The transformation of normal melanocytes into malignant tumor cells has been a focus of research seeking to better understand melanoma's
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 40(8)
Interleukin (IL)-17A is a key proinflammatory cytokine indicated in multiple pathologies, including skin tumorigenesis. While IL-17A is a signature cytokine of Th17 cells, IL-17A is also produced by other cell types, including type 3 innate lymphoid
Publikováno v:
Archives of dermatological research. 313(1)
In addition to its quintessential role in bone homeostasis, vitamin D also plays an important role in regulating the immune system. As such, many studies have demonstrated the therapeutic benefit of vitamin D in treating autoimmune diseases. This imm
Autor:
Laura M. Wingler, Biswaranjan Pani, Dean P. Staus, Paula K. Rambarat, Paul J. Shim, Robert J. Lefkowitz, Jin Lei, Thomas Franch, Mikkel Vestergaard, Lillian D. Sun, Eva Kampmann Olsen, Thomas T. Xu, Li-Yin Huang, Shuai Zhao, Seungkirl Ahn, Gitte Nystrup Husemoen, Alem W. Kahsai, Rishabh K. Simhal, Xin Chen
Publikováno v:
Molecular Pharmacology
Conventional drug discovery efforts at the β2-adrenoceptor (β2AR) have led to the development of ligands that bind almost exclusively to the receptor’s hormone-binding orthosteric site. However, targeting the largely unexplored and evolutionarily
Autor:
Pauline Funchain, Patricia Rayman, Lillian D. Sun, Michael J. McNamara, Charles S. Tannenbaum, Brian R. Gastman, Jung Min Song, C. Marcela Diaz-Montero, Jennifer S. Ko
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)
Journal for ImmunoTherapy of Cancer, Vol 6, Iss 1, Pp 1-7 (2018)
Background Talimogene Laherparepvec (T-VEC) is an oncolytic virus approved as an intratumoral therapy for treating unresectable stage IIIB-IV metastatic melanoma. The mechanisms of action for T-VEC and checkpoint inhibitor are highly complementary. R
Autor:
Douglas R. Green, Lillian D. Sun, Masayuki Kuraoka, Garnett Kelsoe, Alfredo Caro-Maldonado, E. Dale Abel, Amanda G. Nichols, Amanda L. Gavin, Jeffrey C. Rathmell, Sandra Milasta, Ruoning Wang
B cell activation leads to proliferation and antibody production that can protect from pathogens or promote autoimmunity. Regulation of cell metabolism is essential to support the demands of lymphocyte growth and effector function and may regulate to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bb5fe9a2b7e7b9df8ada5e1554e7d7a3
https://europepmc.org/articles/PMC3984038/
https://europepmc.org/articles/PMC3984038/